Aidarex Pharmaceuticals LLC is recalling 35 bottles of Phentermine (USP Capsules, 15 mg) because the medication failed to meet purity specifications during long-term stability testing. This recall involves 30-count bottles that were distributed in California and Nevada. Consumers who have these capsules should check their batch numbers immediately as the medication contains unknown impurities that developed over time.
The medication was found to have unknown impurities and degradation products that exceeded safety specifications during a 30-month stability test. Taking medication that has degraded or contains unidentified impurities can lead to unpredictable side effects or reduced effectiveness.
Healthcare provider consultation and pharmacy refund.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.